The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study

Ähnliche Einträge

• Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, phase 3 trial
  von: Leili Gao, et al.
  Veröffentlicht: (2024)
• Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
  von: Leili Gao, et al.
  Veröffentlicht: (2025)
• Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS‐AP‐Combo
  von: Jianhua Ma, et al.
  Veröffentlicht: (2024)
• Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double‐blind, placebo‐controlled trial
  von: Yingying Xiang, et al.
  Veröffentlicht: (2024)
• Impact of baseline characteristics on the efficacy of once‐weekly subcutaneous semaglutide among participants with type 2 diabetes : A post hoc analysis of SUSTAIN China
  von: Linong Ji, et al.
  Veröffentlicht: (2024)